A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis

NCT00890552 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Amyloidosis

Interventions

DRUG: Lenalidomide
DRUG: Melphalan
DRUG: Dexamethasone

Sponsor

Stanford University

Collaborators

[object Object]